Media Coverage
The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
-
Los Angeles Times
–
What you need to know about COVID vaccines for little kids
Moderna says early findings suggest the vaccine may protect against severe illness in kids just as it does in adults. According to Dr. Bill Muller of Northwestern University, a lull in COVID cases could be “the best time to get immunized because then you’ll be protected by the time the next surge starts.” Muller is a researcher for Moderna’s pediatric studies.
-
Chicago Tribune
–
Northwestern performs rare double lung transplant on patient with terminal lung cancer
Northwestern Medicine surgeons have successfully performed a double lung transplant on a man with terminal lung cancer. His new lungs are now working well, and he seems to be cancer-free. Lung transplants should not replace standard treatments for lung caner, which can include surgery, chemotherapy, immunotherapy and radiation, said Dr. Ankit Bharat, Northwestern chief of thoracic surgery.
-
Fox News
–
Heart disease, stroke deaths rose during COVID-19 pandemic: study
In a study published in the journal JAMA Network Open, authors from Kaiser Permanente, the Permanente Medical Group, the University of California San Francisco and Northwestern University Feinberg School of Medicine said that from 2019 to 2020 the estimated age-adjusted mortality rate increased by 15.9%, largely due to COVID-19 mortality. Rates of stroke and heart disease also increased by 4.3% and 6.4%, respectively.
-
Chicago Tribune
–
Low-dose COVID shots effective for babies and toddlers, Moderna says
Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers – the company announced Wednesday. Vaccinating the littlest “has been somewhat of a moving target over the last couple months,” Dr. Bill Muller of Northwestern University, who is helping study Moderna’s pediatric doses.
-
US News & World Report
–
Moderna Says Its Low-Dose COVID Shots Work for Kids Under 6
Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers. Vaccinating the littlest “has been somewhat of a moving target over the last couple months,” said Dr. Bill Muller of Northwestern University, who is helping study Moderna’s pediatric doses.
-
The Washington Post
–
Moderna said its low-dose COVID shots work for kids under 6
According to Moderna, the company’s COVID-19 vaccine works in babies, toddlers and preschoolers. Dr. Bill Muller of Northwestern University, who is helping study Moderna’s pediatric doses, shared “There’s still, I think, a lingering urgency to try to get that [vaccinating young children] done as soon as possible.”
-
The Wall Street Journal
–
Why Permanent Daylight-Saving Time is Bad for Your Health, Sleep Scientists Say
Permanently moving to daylight-saving time is likely to cause more harm than good when it comes to our health, according to sleep scientists. Because a human’s internal clock is tied to the sun, when the clock springs forward, internal clocks don’t change. According to Phyllis Zee, professor of neurology and director of the Center for Circadian and Sleep Medicine at Northwestern University Feinberg School of Medicine, “Of the three choices – permanent daylight-saving time, permanent standard time or where we are now, which is switching between the two – I think permanent DST is the worst solution”
-
USA Today
–
Moderna to seek FDA authorization for lower-dose COVID vaccine for children under 6
A COVID-19 vaccine for babies and young children may finally be available after Moderna released data showing its vaccine is safe and effective in kids ages 6 months to 6 years. Vaccinating the youngest “has been somewhat of a moving target over the last couple months,” said Dr. Bill Muller of Northwestern University, an investigator in Moderna’s pediatric studies. “There’s still, I think, a lingering urgency to try to get that done as soon as possible.”
-
Chicago Tribune
–
Lake Forest Hospital earns several honors for patient services
Northwestern Medicines’ Lake Forest Hospital has received a series of honors for a number of programs, specifically maternity care and patient safety.
-
NBC 5 Chicago
–
Symptoms, Transmissibility, and More: What We Know About the BA.2 Subvariant
BA.2, known as the “stealth omicron”, is a subvariant of omicron. According to several health experts, BA.2 seems to be more transmissible than omicron. Northwestern’s Dr. Michael Angarone, an associate professor of medicine in infectious diseases, said the increased transmissibility could be strong in close contacts of those infected, however it is still to early to know for sure.
